Novartis will acquire Calypso Biotech, a developer of Interleukin15 (IL-15) targeted therapies, for US$250 million plus a further $175 million based on the achievement of certain predetermined milestones.

PrecisionLife, and leading US multi-specialty healthcare center, and Metrodora Institute, are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren’s syndrome, and many more. The partners will first develop and validate genotypic diagnostics that provide clinicians with an accurate […]

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), has appointed Joseph Parisi as US Director of Sales. In his new role, Parisi will lead the expansion of the company’s sales and support activities for the US market to address the growing demand for new alternative methodologies […]

The Clinical and Laboratory Standards Institute (CLSI) has implemented new Country-Based Pricing

Australian, European and U.S. clients are now able to tap into world-class strategic advice and full-service clinical trial capabilities following the announcement of Biointelect’s and CR2O’s new strategic partnership.